Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Chronic Pouchitis
NCT01670240Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Aug 2012
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pouchitis comparing Adalimumab with Placebo (2 arms). Primary endpoint: Clinical response on treatment with Adalimumab at 12 weeks. Started Aug 2012; status: completed.
02
Drugs
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT01670240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670240.